New Molecular Targets for Antidepressant Drugs
Major depressive disorder (MDD) is a common and severe mental disorder that is usually recurrent and has a high risk of suicide. This disorder manifests not only with psychological symptoms but also multiple changes throughout the body, including increased risks of obesity, diabetes, and cardiovascu...
Main Authors: | Johannes Kornhuber, Erich Gulbins |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/9/894 |
Similar Items
-
Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity
by: Samar Sami Alkafaas, et al.
Published: (2024-02-01) -
Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons
by: Nadine eBeckmann, et al.
Published: (2014-09-01) -
Keep Your Friends Close, but Your Enemies Closer: Role of Acid Sphingomyelinase During Infection and Host Response
by: Ha-Yeun Chung, et al.
Published: (2021-01-01) -
Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
by: Murad Abusukhun, et al.
Published: (2021-12-01) -
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study
by: Nicolas Hoertel, et al.
Published: (2023-08-01)